Maintain, if not increase your clinical performance¹

The iCAD reader study shows not only increased sensitivity, but most importantly specificity, which means that ProFound AI performs better than conventional 2D CAD with regard to false positives¹.

iCAD Reader Study results²

An iCAD reader study showed up to 50% reduction in reading time when using ProFound AI compared to without, while increasing sensitivity up to 8% and, most importantly, specificity up to 6,9%2 which means that ProFound AI encompasses the limitations of 2D CAD with regards to False Positive rate. The same study also reports a decrease in recall rate up to 7,2%.

Leverage the power of AI
to help you reduce your DBT reading time

    Seamless integration on Seno Iris™ SP3

    Clinical cases

    • Invasive Ductal Carcinoma

      Screening recall

    GE Mammography

    Related Products

    1. Compared to reading without ProFound AI. iCAD labelling and user manual, DTM160 rev C.
    2. CAD labeling and User Manual DTM160 Rev.C. Reading times may vary based on the specific functionality of the viewing application used for interpretation.

    Product may not be available in all countries and regions.
    Full product technical specification is available upon request.
    GE, the monogram, Senographe Pristina, Seno Iris are trademarks of General Electric Company.
    iCAD, the iCAD logo and ProFound AI, are trademarks of iCAD, Inc.

    JB09212XX